The y-lysin determinant of Staphylococcus aureus strain Smith 5R has been cloned in phage I and plasmid vectors in Escherichia coli. Genetic evidence is presented which demonstrates that y-lysin requires the co-operative action of two polypeptides expressed by the closely linked hlgA and hlgB genes. Recombinants expressed haemolytic activity in agarose medium but not in agar, a known property of y-lysin. Haemolysis was inhibited by antiserum raised against the 32 kDa component of y-lysin, but not by anti-or-, anti-/?-or anti-d-lysin senlm. Subcloning and transposon Tn5 mutagenesis identified a 3-5 kb region which was necessary for y-lysin expression in E. coli. Two genes (hlgA and hlgB) were mapped and their polyoeptide products identified. Non-haemolytic Tn5 mutants fell into two groups based upon complementation tests done between extracts of mutants in vitro and also between extracts of mutants and components of y-lysin purified from S. aureus culture supernates. Immunoblotting showed that some mutants in group A (defective in expression of hlgA) did not express a 32 kDa polypeptide which was synthesized by the parental haemolytic recombinant and by mutants in group B. Minicell analysis suggested that the products of the hlgB gene were proteins of 38 kDa and 36 kDa. The smaller molecule co-migrates with a protein in a fraction of the S. aureus culture supernate containing component B of y-lysin. The 38 kDa polypeptide is probably an unprocessed precursor. Southern hybridization demonstrated that the hlgA and hlgB genes are closely linked in the chromosome of several strains of S. aureus.
INTRODUCTION
Staphylococcus aureus is a Gram-positive pathogenic bacterium which causes a variety of human tissue infections including furuncles, wound sepsis, osteomyelitis and endocarditis. It produces an array of extracellular and cell-bound proteins which are potentially important in pathogenesis (for reviews see McCartney & Arbuthnott, 1978; Easmon & Adlam, 1983) . These include several cytolytic toxins, of which y-lysin is one of the least well characterized. The organism is also the major cause of mastitis, an economically important disease of dairy cattle (Anderson, 1983) .
Several groups have reported the purification of y-lysin, but there is conflicting evidence about the number of polypeptide components, their molecular masses and their isoelectric points. Mollby & Wadstrom (1971) described a single 30 kDa polypeptide of PI 9.5, while Fackrell & Wiseman (1976a, b) reported a single 45 kDa protein of PI 6.0. Others have shown that haemolytic activity requires two polypeptides (Guyonnet & Plommet, 1970; Guyonnet et al., 1968; Taylor & Bernheimer, 1974) of 29 kDa and 26 kDa with PI values of 9-9 and 9-8, respectively (Taylor & Bernheimer, 1974) .
Little is known about the mode of action of y-lysin or of its role in pathogenesis. Elevated titres of antibodies to the lysin have been detected in sera of patients with osteomyelitis (Taylor & Plommet, 1973) , showing that y-lysin is expressed in uiuo during chronic infections. More recently it has been shown that most toxic-shock-syndrome-associated strains of S. aureus produce y-lysin but fail to produce a-toxin or p-toxin (Clyne et a/., 1987).
One method of testing the role of a toxin in pathogenesis is to examine the virulence of toxindeficient mutants in experimental infections (Sparling, 1983; Jonsson et al., 1985 ; O'Reilly et al., 1986) . In order to facilitate the future isolation of y-lysin-deficient mutants we set out to clone and map the determinant from strain Smith 5R. Another objective was to determine unambiguously the number of polypeptides involved in y-lysin activity.
METHODS
Bacterial strains,plasmids andphuges. The bacterial strains are listed in Table 1 and the plasmids in Table 2 . The replacement vector 1L47.1 (Loenen & Brammar, 1980) was used to clone the hlg determinant. 1467 (cI857 rex : : Tn5 029 p80) was obtained from N. Kleckner (Harvard University, Cambridge, USA).
Bacteriological media. Escherichia coli strains were grown in L broth and on L agar (Miller, 1972) . S. aureus was cultured in Trypticase Soy Broth and Agar (Oxoid). 1 phages were propagated in 1 base and top agar (Miller, 1972) . Brain heart infusion broth (Oxoid) was used for culturing E. coli DS410 strains for producing minicells (Dougan & Kehoe, 1984) .
Chemicals and enzymes. Chemicals were obtained from Sigma or were the best grade available from BDH. Ampicillin (Ap), kanamycin (Km) and tetracycline (Tc) were purchased from Sigma. Restriction enzymes and T4 DNA ligase were obtained from the Boehringer Corporation and were used according to the manufacturer's instructions.
Antisera. Rabbit antisera prepared against y-lysin were from two sources. Dr T. H. Birkbeck (Microbiology Department, Glasgow University, UK) kindly provided the serum which was used in early experiments. More recently serum against the purified 32 kDa component of y-lysin was kindly provided by M. Clyne (Microbiology Department, Trinity College, Dublin) . Anti-a-, anti-8-and anti-b-lysin sera were generously supplied by Dr C. Adlam (Wellcome Biotechnology, Beckenham, UK).
Assays for haernolytic activity. E. coli strains were tested for haemolysis by stabbing colonies onto L agarose plates containing 5 % (v/v) washed rabbit erythrocytes and incubating at 37 "C for 24 h. Haemolytic titrations were Immunochemical analysis of y-lysin. Proteins produced in 1hlg lysates were prepared as described previously (O'Toole & Foster, 1986a) . Lysates of pJC-plasmid-carrying strains of E. coli were prepared by sonication of cells from 100 ml L broth cultures grown to stationary phase in 250 ml flasks shaken at 150 r.p.m. at 37 "C for 18 h. Cells were concentrated 30-fold in PBS. Proteins were separated by SDS-PAGE (Laemmli, 1970) and subjected to immunoblotting (Burnette, 1981) . Filters were incubated with rabbit antiserum prepared against the purified 32 kDa component of y-lysin followed by peroxidase-conjugated protein A. Colony immunoblotting was done by the method of Helfman et al. (1983) .
Tramformation. E. coli strains were transformed with plasmid DNA as described by Maniatis et al. (1982) . Molecular cloning. DNA manipulations were performed using standard procedures (Maniatis et al., 1982) .
A library of S. aureus Smith 5R DNA was constructed in 1L47.1 as described previously (O'Toole & Foster, 1986a) , except that the genomic DNA was cleaved partially with Sau3AI and the A replacement vector was cut with BamHI. Recombinant phages from the library were plated on E. coli C600 and plaques were screened by overlaying with agarose containing rabbit erythrocytes. Plaques producing a zone of haemolysis after a further 4-8 h incubation at 37 "C were picked and purified. They were replated and the identity of the haemolysin was tested by placing small drops of antisera specific for S. aureus haemolysins over the plaques prior to incubation with the erythrocyte overlay. Only anti-y-lysin serum inhibited haemolysis, whereas anti-fl-, anti-6-and anti-alysin sera had no effect. In addition, substitution of agar for agarose in the erythrocyte overlay inhibited haemolysis. y-Lysin is inhibited by sulphonated residues in agar (Guyonnet & Plommet, 1970) . A 7.9 kb HindIII fragment was subcloned from h l g into pBR322, forming pJCOl ( Fig. 1 ). Subsequently a 6 kb EcoRV fragment was subcloned from pJCOl into pBR322, forming pJCO8 ( Fig. 1 ). E. coli C600 cells containing either plasmid produced haemolytic activity when concentrated lysates were tested (4 and 64 HU ml-', respectively) but colonies were not haemolytic when grown on L agarose incorporating rabbit erythrocytes. Consequently, a 6 kb HindIII fragment was subcloned from pJCO8 into the expression vector pKK233-2 (Amann & Brosius, 1985), forming pJCO9 ( Fig. 1 ). pKK233-2 has the strong trc promoter located adjacent to the HindIII cloning site. In the lael+ strain C600 the trc promoter is expressed constitutively, presumably because the small number of lac repressor molecules are titrated out by multiple copies of the lac operator. E. coli C600 carrying plasmid pJCO9 formed colonies on L agarose erythrocyte medium which were surrounded by haemolysis after 18 h incubation, and lysates contained 128 HU ml-* .
In order to construct a vector plasmid which lacked the /?-lactamase determinant, for use in minicell experiments, the 1-07 and 0.92 kb PstI fragments of Tn5 (which carry the Kmr marker) were cloned into the PstI site of pBR322, forming pJC10. A 7.2 kb PvuI-BamHI fragment from pJCO9 carrying the entire hlg insert linked to the trc promoter ( Fig. 1) was subcloned into pJCl0 cleaved with PvuI and BamHI to form pJCl1. This plasmid expressed y-lysin at the same level as pJCO9.
Transposon mutagenesis. Transposon Tn5 mutagenesis was performed by infecting E. coli strain XAcSucarrying pJCO9 with 1467 as described previously (Coleman & Foster, 1981) .
Minicells. Polypeptides specified by hlg plasmids were detected using the minicell system. E. coli strain DS410 was transformed with plasmids and minicells were prepared, labelled and fractionated as described by Dougan & Kehoe (1984) . Samples were chased for 45 min at 37 "C with unlabelled methionine after the labelling step in order to reduce the level of the fl-lactamase precursor (Dougan & Kehoe, 1984) .
Southern hybridization. Probes were labelled by nick-translation in vitro (Rigby et al., 1977) and Southern blot hybridization (Southern, 1975 ) was carried out as described in Maniatis et al. (1982) . The 1-4 kb XbaI fragment which spans hlgA, and the 1.2 kb EcoRI-XbaI fragment covering hlgB (Fig. l) , were used as probes.
RESULTS

Analysis of the cloned y-lysin determinant
The y-lysin determinant, cloned in the expression vector pKK233-2 (pJCO9), was mapped with restriction enzymes and analysed by transposon Tn5 mutagenesis. Ten independent Tn5 insertions which abolished the ability of pJCO9 to express haemolysis around colonies were
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I111 /I I111 - isolated and mapped (Fig. 1) . The insertions spanned 3.5 kb. One mutant (number 1) mapped in the small piece of pBR322 DNA located between the cloned hlg sequences and the vector. This implies that Tn5 is preventing expression of haemolytic activity in this mutant (and possibly some others) by polarity. Extracts of cells carrying mutants 3, 5 and 6 had 128, 32 and 32 HU ml-l respectively whereas the other mutants were devoid of detectable haemolytic activity.
Complementation tests Samples of lysates of E. coli C600 carrying pJC09hlg : :Tn5 mutant plasmids were tested in all paired combinations for enhanced haemolysis. One example of a complementation test is shown in Fig. 2(a) . The mutants fell into two classes based on complementation of haemolytic activity. Mutants 1, 2, 3, 4 and 5 , mapping in the trc-promoter-proximal region, each complemented mutants 6, 7, 8, 9 and 10, which are clustered distally to the trc promoter. The mutants thus formed two complementation groups, which we designated A and B, respectively. Mutant 6 also complemented mutants 7-10 in a diffusion test that took 7 d to give a result.
Complementation tests were also performed between extracts of mutants from groups A and B and y-lysin components purified from culture supernates of S. aureus. Lysates of group B mutants underwent complementation with a fraction containing the 36 kDa protein, while group A mutants were complemented by the 32 kDa component (Fig. 26 ). This suggests that group A mutants are deficient in expression of the 32 kDa protein while group B strains lack the 36 kDa peptide.
Analysis of hlg-specified polypeptides Immunoblotting was done with extracts of strains carrying pJC09hlg : : Tn5 plasmids using antiserum raised against the purified 32 kDa component of y-lysin. Mutants 3,5,6,7,8,9 and 10 produced an immunoreactive protein of 32 kDa while mutants 1, 2 and 4 did not (Fig. 3) . The The middle band present in some samples is probably a breakdown product of the 32 kDa protein, while the lower band is an E. cofi antigen, antibodies to which are present in rabbit serum and which were not completely adsorbed.
two complementation group A mutants which expressed immunoreactive protein were those that also had haemolytic activity in lysates. All group B mutants expressed an immunoreactive protein.
Polypeptide expression of the cloned hlg determinant was analysed using the E. coli minicell system. In addition to pJCO9 and the pJC09hlg: :Tn5 mutants used in the experiments described above, an additional plasmid carrying hlg (pJC11) which lacked a Ij-lactamase determinant was studied. Wild-type plasmids pJCO9 and pJCl1 and mutant 4 in complementation group A expressed polypeptides of 38 and 36 kDa which were absent in vector controls (Fig.  4 , tracks E, G and I). The other group A mutants also expressed these proteins (data not shown).
The 36 kDa protein comigrated with a polypeptide in the fraction of an S. aureus Smith 5R
culture supernate containing the y-lysin B component (Fig. 4, track B ). Tn5 mutants 8 and 10 in complementation group B were tested in the minicell system and were shown to lack the 38 and 36 kDa polypeptides while for mutant 6, trace amounts were observed (Fig. 4 , tracks H, J and K). (Mutant 6 was the only group B mutant to express haemolytic activity in lysates.) These results suggest that the 38 kDa and 36 kDa proteins are products of the hlgB gene. It seems likely that the 38 kDa protein is a precursor of the 36 kDa component B of y-lysin.
The 32 kDa product of the hlgA gene was also discernible in the pJCl1 sample, which lacked TEM j-lactamase (Fig. 4, track G) , but it migrated too close to j-lactamase to be identified in pJCO9 or the Tn5 mutants.
Southern blot hybridization
The method used to construct the library of S . aureus Smith 5R DNA allowed the possibility that different genomic fragments could have been mixed in the same vector. In order to confirm that the hlgA and hlgB genes are linked in the chromosome of S. aureus in the same way as in pJCO9 (Fig. 1) , Southern blot hybridization analysis was done with DNA of strains Smith 5R, 8325-4 and M60. Genomic DNA was cleaved with restriction endonucleases HindIII and PstI, enzymes that do not cleave within the cloned Smith 5R hlg determinant (Fig. 1) . Samples were hybridized with probes specific for the hlgA and hlgB genes. In strain Smith 5R the two probes hybridized to HindIII fragments of the same size (Fig. 5, tracks N and T) . Similar results were obtained when DNA from strains M60 and 8325-4 was tested (Fig. 5 , tracks L, J, R and P). Interestingly, the 8325-4 and M60 samples revealed the presence of an additional HindIII site within the region cloned from strain Smith 5R because two fragments hybridized to the probes rather than one (Fig. 5, tracks P and R) . The same type of result was obtained when the chromosomal DNA was cut with PstI (Fig. 5 , tracks I , K, My 0, Q and S). Thus the hlgA and hlgB probes hybridized to genomic fragments of the same size (with the exception of 8325-4 and M60 DNA cleaved with HindIII and probed with hlgA). These results are consistent with the genes being closely linked in the S . aureus chromosome.
The cloned hlgA and hlgB genes are located on contiguous XbaI fragments of 1.4 and 1-45 kb in pJCO9 (Fig. 1) . Fragments of 1-4 kb hybridized when genomic DNA of the three strains was cleaved with XbaI and probed with the hlgA specific probes (Fig. 5 , tracks A-D) . A 1-45 kb fragment hybridized to the hlgB probe (Fig. 5 , tracks E-H).
DISCUSSION
In this paper we present molecular genetic evidence that the y-lysin determinant of S . aureus requires the synergistic activity of two proteins. The gene products were identified by immunoblotting and in the minicell system as proteins of 32 kDa and 36 kDa. The genes which code for the proteins (hlgA and hlgB, respectively) were mapped. In vitro complementation tests between extracts of E. coli strains carrying mutant plasmids provide convincing evidence that y-lysin involves two components. This was supported by the complementation that occurred between extracts of mutants and purified components of y-lysin.
Physical mapping of the hlg : :Tn5 insertions allowed the complementation groups to be correlated with two discrete clusters of mutants. Mutants 6 , 7, 8, 9 and 10 in complementation group B define the hlgB gene. Group A comprises mutants 1 , 2,3,4 and 5 . However, the group A mutants span 2.5 kb of DNA, which is much longer than is required to code for the putative hlgA gene product of 32 kDa. Mutation 1 is actually located in a small section of pBR322 DNA located between the trc promoter of pKK233-2 and the cloned sequences. It is thus likely that Tn5 mutants 1 and 2 fail to express haemolysin due to polarity. If this is so, the promoter for the hlgA gene must be poorly expressed in E. coli. This is consistent with the level of expression of haemolysin by pJCO1, pJCO8 and pJCO9. Plasmid pJCOl expresses a very low level of haemolysin which is detectable only in extracts. In subcloning hlg to form pJCO8, the hlgA gene was moved closer to the tet promoter of pBR322 and a higher level of expression was measured. When the fragment was recloned so that hlgA was downstream from the trc promoter, a higher level of haemolysin was observed. In addition, pJC09-carrying cells formed colonies which were haemolytic on blood agar. These results imply that the hlgA promoter is not active in E. coli and furthermore the direction of transcription of hlgA can be inferred to be from left to right as indicated in Fig. 1 .
The data also suggest that the hlgA and hlgB genes are expressed from different promoters in E. coli. This may also be the case in S . aureus. Strongly polar Tn5 insertions in group A still express the 36 kDa protein product of the hlgB gene, as detected in minicells and in complementation tests. Indeed the direction of transcription of hlgB relative to hlgA is unknown.
Two mutants in complementation group A produced measurable amounts of haemolysin and a protein that cross-reacted immunologically with the 32 kDa component of y-lysin. The most likely explanation is that mutation 3 is weakly polar in comparison to mutations 1 and 2 (Tn5 polarity is variable: Berg et al., 1980) . Mutations 4 and 5 are probably located in the hlgA structural gene since they are the group A mutations most distal to the trc promoter. However, mutant 5 also produces a protein which cross-reacts with the 32 kDa y-lysin component and is weakly haemolytic. Perhaps Tn5 has inserted in the 3' end of the hlgA coding sequence resulting in a partly functional protein.
All mutants in complementation group B failed to produce 38 kDa and 36 kDa proteins and were non-haemolytic, with the exception of mutant 6, which had weak haemolytic activity and expressed reduced levels of the proteins in minicells. In addition, mutant 6 complemented mutants 7-10 in a very slow reaction. We suggest that the transposon is located in the intercistronic region between hlgA and hlgB, possibly in the promoter or regulatory region of the hlgB gene, and reduces expression of the 38 kDa and 36 kDa proteins. It seems likely that the 38 kDa protein is the unprocessed form of the 36 kDa protein which normally appears in S. aureus culture supernates. The latter protein comigrated with component B of y-lysin from S. aureus. Both proteins are missing in hlgB : :Tn5 mutants.
The results imply that hlgB is expressed from its own promoter in E. coli. According to complementation tests the promoter-proximal insertions 1-5 express the 36 kDa protein and they all complement mutants in group B. Thus we can conclude that the hlgA and hlgB genes are expressed from separate promoters in E. coli. The hlgA promoter may be similar to the promoters of the epidermolytic toxin B (O'Toole & Foster, 19866) and enterotoxin B genes (Ranelli et al., 1985) of S. aureus, which are not expressed in E. coli. The possibility that the hlgA promoter was lost during the cloning seems unlikely unless the hlgA gene is part of a larger transcription unit.
Southern blot hybridization showed that the hlgA and hlgB genes were linked in the chromosomes of S. aureus, thus eliminating the possibility that linkage was generated during cloning in the phage vector. Two restriction enzymes which did not cleave within the hlg locus cloned in pJCO9 were used to cut genomic DNA. The hlgA and hlgB probes hybridized to HindIII fragments of the same size in S. aureus strain 8325-4. A similar result was obtained for strains M60 and Smith 5R and when genomic DNA was cut with PstI. Thus the hlgA and hlgB genes are probably located on the same fragments (in M60 and 8325-4 an additional HindIII site is present in the hlgA gene). Further evidence for linkage was obtained from hybridization of XbaI-cleaved DNA. The hlgA and hlgB genes are located on adjacent XbaI fragments of 1.4 kb and 1.45 kb, respectively, in pJCO9. Chromosomal DNA fragments of the same size hybridize, which also supports the notion that close linkage of the genes was not created during cloning. If the genes were not linked then at least one XbaI fragment of different size would be expected in hybridizations.
There is no compelling evidence for an important role for y-lysin in pathogenesis of S. aureus infections. We propose to examine this question by isolating specific mutants in the hlgA and hlgB genes using allele-replacement (O'Reilly et al., 1986) and by testing their virulence in experimental infections. 
